DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Ambery P, Parker VE, Stumvoll M. et al.
MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight
patients with type 2 diabetes: A randomised, controlled, double-blind, ascending
dose and phase 2a study.
Lancet 2018;
391: 2607-2618
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.